- Home
- IBRX vs BB Comparison
IBRX vs BB Comparison
Compare IBRX & BB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- BB
- Stock Information
- Founded
- IBRX 2014
- BB 1984
- Country
- IBRX United States
- BB Canada
- Employees
- IBRX N/A
- BB N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- BB
- Sector
- IBRX Health Care
- BB
- Exchange
- IBRX Nasdaq
- BB Nasdaq
- Market Cap
- IBRX 2.3B
- BB 2.3B
- IPO Year
- IBRX N/A
- BB 1997
- Fundamental
- Price
- IBRX $2.44
- BB $3.62
- Analyst Decision
- IBRX Strong Buy
- BB Buy
- Analyst Count
- IBRX 5
- BB 6
- Target Price
- IBRX $11.40
- BB $4.64
- AVG Volume (30 Days)
- IBRX 7.6M
- BB 8.8M
- Earning Date
- IBRX 08-05-2025
- BB 09-25-2025
- Dividend Yield
- IBRX N/A
- BB N/A
- EPS Growth
- IBRX N/A
- BB N/A
- EPS
- IBRX N/A
- BB N/A
- Revenue
- IBRX $56,600,000.00
- BB $533,200,000.00
- Revenue This Year
- IBRX $567.98
- BB $2.17
- Revenue Next Year
- IBRX $160.56
- BB $7.03
- P/E Ratio
- IBRX N/A
- BB N/A
- Revenue Growth
- IBRX 4227.22
- BB 4.65
- 52 Week Low
- IBRX $1.83
- BB $2.14
- 52 Week High
- IBRX $7.48
- BB $6.24
- Technical
- Relative Strength Index (RSI)
- IBRX 40.38
- BB 35.34
- Support Level
- IBRX $2.33
- BB $3.57
- Resistance Level
- IBRX $2.46
- BB $3.78
- Average True Range (ATR)
- IBRX 0.15
- BB 0.13
- MACD
- IBRX -0.03
- BB -0.02
- Stochastic Oscillator
- IBRX 14.10
- BB 11.02
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About BB BlackBerry Limited
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.